eSolar and B&W PGG Receive Government Funding to Build Concentrating Solar Power Project

eSolar, an Idealab company that formulates modular and scalable solar thermal power plant technology and, its project associate  Babcock & Wilcox Power Generation Group which offers nuclear and fossil power technology  is chosen by the  U.S. Department of Energy to receive $10.8 million subsidy to plan, build and run a modular, baseload molten salt power plant utilizing concentrated solar power.

Babcock & Wilcox Power Generation on its part will offer turnkey modular molten salt receiver that works with eSolar technology, which is a hot/cold molten salt storing system, and molten salt to steam heat exchangers. The company aspires to realize lowest levelized electricity in a utility scale CSP plant.

The proposed plant is planning to use ample mirrors to converge solar power on a receiver mounted over a tower. The heat energy focused on the receiver will be transferred to a steam generator through molten salt to produce steam and in turn electrical energy. The heated molten salt can be used to power the steam generator during eclipse period of sun thus permitting power production up to 18 hours in a day.

Richard L. Killion President and Chief Operating Officer of B&W PGG felt energized about the US government’s support and said the environment friendly technology, of using concentrated solar power on molten salt will help to meet the energy needs of the nation cost effectively.

John Van Scoter, CEO of eSolar was gratified that eSolar is on par with the companies that work for CSP market and said together with B&W PGG, they intend to speed up the research, for attaining cost effective storage solutions for CSP which is crucial for the industry’s subsequent stratum of expansion.

B&W PGG is planning to outsource the required components and assemble them in the proposed site to trim overheads. Designing, building and testing of this project is expected to be completed approximately in 2.5 years.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.